The international biotech community will gather in Melbourne, Australia - one of the world’s greatest biotech hubs - for the 17th International Biotechnology Symposium and Exhibition (IBS 2016), from 24 – 27 October 2016.
IBS is organised under the auspices of the International Union of Pure and Applied Chemistry (IUPAC) since 1960 and is the most representative biotechnology event at the global level, at which more than 1,000 participants congregate from academia and industry, to explore the advances and frontiers of science and applied biotechnologies.
IBS intends to present and promote the relevant contribution that chemistry provides to the development of biotechnological research and industry.
The IBS 2016 program will present the most advanced issues in biotechnology, green chemistry and its related fields, which will be discussed by a selected group of international speakers and lecturers. Topics will include agri-business; industrial and environmental biotechnology; pharmaceutical, medical and molecular; bioenergy and bio-refinery; the bio-economy, policy and investment; and biosensors and nanotechnology.
Melbourne is an exciting, multicultural city that blends the beautiful natural sceneries with cosmopolitan modern lifestyle. The venue for IBS 2016, Melbourne Convention and Exhibition Centre, is surrounded by restaurants, cafes, shops and galleries for you to enjoy.
IBS 2016 will held as one of three major events that together make up the International BioFest 2016, Australia’s largest-ever gathering of the life sciences. The International BioFest 2016 also includes:
In addition to a progressive and relevant IBS 2016 conference program, delegates will have access to outstanding networking opportunities at the combined welcome reception, gala conference dinner and in the exhibition hall.
We look forward to welcoming you to Melbourne.
For further information please contact National Conference and Events Manager, Kirsty Grimwade
Improving 'last resort' antibiotics: Dr Kade Roberts, Senior Research Scientist, Monash University
Dr Roberts will discuss how he and fellow team members of the Li Lab are developing novel, safer polymyxins for treating dangerous ‘super-bugs’, which represent a major global health problem.
Distinguished Prof Margaret Brimble, Chair of Organic Chemistry and Director of Medicinal Chemistry at the University of Auckland
Professor Brimble’s lecture will focus of her research – the synthesis of bioactive natural products and the synthesis of peptides, lipopeptides and glycopeptides as potential therapeutic agents.
Experienced in the prevention of hepatitis and AIDS that earned him an the Order of Australia and part of the team that transformed CSL into a major publically listed company, Prof Gust will deliver messages useful to people seeking global success in science, academia and start-ups.